harmol

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameharmol
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMediProPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediProPharma Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A